Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Harvard Business School
Julphar
Express Scripts
Citi
Chinese Patent Office
Teva
Healthtrust
Argus Health

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 8,080,654

« Back to Dashboard

Title:Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors
Abstract: The present invention relates to macrocyclic a compound of formula (I) and its use as inhibitors of the hepatitis C virus (HCV) NS3 protease, and in treating or preventing HCV infections. ##STR00001##
Inventor(s): Harper; Steven (Pomezia, IT), Summa; Vincenzo (Pomezia, IT), Liverton; Nigel J. (Harleysville, PA), McCauley; John A. (Maple Glen, PA)
Assignee: Insituto di Ricerche di Biologia Molecolare P. Angeletti SpA (Rome, IT) Merck Sharp & Dohme Corp. (Rahway, NJ)
Filing Date:May 20, 2011
Application Number:13/112,281
Claims:1. A method of preparing a compound of formula (I): ##STR00029## said method comprising: reacting (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,- 18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,- 6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid ##STR00030## with (1R,2S)-1-Amino-N-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide hydrochloride ##STR00031##

2. The method of claim 1, wherein the reacting is conducted in the presence of at least one reagent selected from the group consisting of diisopropylethylamine (DIEA), dimethylamino pyridine (DMAP) and O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU).

3. The method of claim 1, wherein the reacting is conducted in the presence of diisopropylethylamine (DIEA), dimethylamino pyridine (DMAP) and O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium tetrafluoroborate (TBTU).

4. A method of preparing a pharmaceutically acceptable salt of a compound of formula (I): ##STR00032## said method comprising: reacting a compound of formula (I) with a metal alkoxide to form a salt or the compound of formula (I).

5. The method of claim 4, wherein the metal alkoxide is a potassium alkoxide.

6. The method of claim 5, wherein the potassium alkoxide is a potassium tert-butoxide.

7. A compound prepared by the method of claim 1.

8. A compound prepared by the method of claim 4.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
AstraZeneca
Merck
US Department of Justice
Fuji
Julphar
QuintilesIMS
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.